Bioxcel Therapeutics Logo

Innovative Medicine Backed by the Power of AI

BioXcel Therapeutics, Inc. is a
biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.

Innovative Medicine
Backed by the
Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Innovative Medicine
Backed by the Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Our Approach to Drug Development

AI-based Drug Development

Our neuroscience and immuno-oncology franchises utilize our AI
approach to drug identification and development

Neuroscience

BXCL501-Neuroscience-image

Immuno-Oncology

BXCL701-Immuno-Oncology-image

Latest News

Nov 14, 2022
BioXcel Therapeutics to Present at Two Upcoming Investor ConferencesVIEW RELEASE
Nov 10, 2022
BioXcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational HighlightsVIEW RELEASE
Oct 27, 2022
BioXcel Therapeutics to Report Third Quarter 2022 Financial Results on November 10, 2022VIEW RELEASE

Stock Information

BioXcel Therapeutics, Inc.

Jan 01, 1970 12:00 AM

MARKET/SYMBOL

Nasdaq:

BTAI

PRICE

15.61

CHANGE

0.1 (0.64%)